Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Fitzgerald (Perth, Australia), S. Muruganandan (Perth, Australia), C. Stanley (Perth, Australia), A. Badiei (Perth, Australia), K. Murray (Perth, Australia), C. Read (Perth, Australia), Y. Lee (Perth, Australia). EPIToME (Early Pleurodesis via IPC with Talc for Malignant Effusion): Evaluation of a new management algorithm. 493

Member's Comments

No comment yet.

Related content which might interest you: Management of recurrent Malignant Pleural Effusion: what is the best method? Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 Management of recurrent Malignant Pleural Effusion: what is the best method? Source: ERS Course 2015 Year: 2015 Efficacy And Safety Of Thoracoscopic Cryobiopsy In Patients With Undiagnosed Exudative Pleural Effusion Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020 Thoracoscopy: Outcomes in non-diagnostic procedures Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 The role of a pleural service in optimising pleural disease management Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Intrapleural photodynamic therapy for malignant pleural mesothelioma: A new dosimetry approach Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Efficacy of Matrix Metalloproteinase-9 in Differentiating Tuberculous from Non-Tuberculous Pleural Effusion Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Role of Biomarkers for Predicting suspecting Malignant Mesothelioma in patients with Pleural Effusion presenting to a tertiary care hospital Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 Pleural effusions after cardiac surgery: Etiology and outcomes Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Is it Time for Endobronchial Therapy to Replace Surgery in the Treatment of Typical Endobronchial Carcinoid? Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches Year: 2020 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Malignant Mesothelioma: Place for thoracoscopy Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 Malignant Mesothelioma: Place for thoracoscopy Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 Biological markers of successful pleurodesis for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016